Alice Tsai - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Alice Tsai

Showing results (31-40 of 34) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 34 results.

ACS Medicinal Chemistry Letters|February 16, 2017

Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.

Cancer Discovery|April 19, 2026

TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.

Journal of Medicinal Chemistry|July 15, 2014

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2Michael P Clark, Mark W Ledeboer, Ioana Davies, et al.

Cancer Research|August 29, 2025

TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.

Pageof 4

Search research articles

Showing results (31-40 of 34) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 34 results.

ACS Medicinal Chemistry Letters|February 16, 2017

Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.

Cancer Discovery|April 19, 2026

TNG961 is a selective oral HBS1L molecular glue degrader for the treatment of FOCAD-deleted cancersHilary E Nicholson, Douglas A Whittington, Frank J Bruzzese, et al.

Journal of Medicinal Chemistry|July 15, 2014

Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2Michael P Clark, Mark W Ledeboer, Ioana Davies, et al.

Cancer Research|August 29, 2025

TNG260 is a Small-Molecule CoREST Inhibitor that Sensitizes STK11-Mutant Tumors to Anti-PD-1 ImmunotherapyLeanne G Ahronian, Soumyadip Sahu, Minjie Zhang, et al.

Pageof 4